Status:
COMPLETED
Satisfaction With Phosphodiesterase 5 Inhibitors Treatment In Patients With Cardiovascular Risk
Lead Sponsor:
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Conditions:
Erectile Dysfunction
Eligibility:
MALE
18+ years
Brief Summary
Evaluate satisfaction in people treated with IPDE5 inhibitors over time
Detailed Description
12 first patients that are eligible
Eligibility Criteria
Inclusion
- CV risk factors
- Male above 18
Exclusion
- Non-informed consent
Key Trial Info
Start Date :
December 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2008
Estimated Enrollment :
720 Patients enrolled
Trial Details
Trial ID
NCT00874185
Start Date
December 1 2007
End Date
May 1 2008
Last Update
February 1 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.